BRAF and melanoma: The hyperactivation of MAPK pathway due to oncogenic mutation of BRAF (Rapidly Accelerated Fibrosarcoma kinase isoform B) occurs in 70% of melanoma cases [10,11], 10% of colorectal cases [12], and 70% of thyroid cancer cases [13,14,15].